These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23082977)

  • 21. How to design potent and selective DYRK1B inhibitors? Molecular modeling study.
    Szamborska-Gbur A; Rutkowska E; Dreas A; Frid M; Vilenchik M; Milik M; Brzózka K; Król M
    J Mol Model; 2019 Jan; 25(2):41. PubMed ID: 30673861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design.
    Han W; Ding Y; Xu Y; Pfister K; Zhu S; Warne B; Doyle M; Aikawa M; Amiri P; Appleton B; Stuart DD; Fanidi A; Shafer CM
    J Med Chem; 2016 Apr; 59(7):3034-45. PubMed ID: 27002243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Death-associated protein kinase as a potential therapeutic target.
    Schumacher AM; Velentza AV; Watterson DM
    Expert Opin Ther Targets; 2002 Aug; 6(4):497-506. PubMed ID: 12223064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Luteolin suppresses cancer cell proliferation by targeting vaccinia-related kinase 1.
    Kim YS; Kim SH; Shin J; Harikishore A; Lim JK; Jung Y; Lyu HN; Baek NI; Choi KY; Yoon HS; Kim KT
    PLoS One; 2014; 9(10):e109655. PubMed ID: 25310002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
    Lee N; Kwon JH; Kim YB; Kim SH; Park SJ; Xu W; Jung HY; Kim KT; Wang HJ; Choi KY
    Oncotarget; 2015 Oct; 6(30):30130-48. PubMed ID: 26375549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells.
    Kim SH; Ryu HG; Lee J; Shin J; Harikishore A; Jung HY; Kim YS; Lyu HN; Oh E; Baek NI; Choi KY; Yoon HS; Kim KT
    Sci Rep; 2015 Sep; 5():14570. PubMed ID: 26412148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer.
    Lee N; Kim DK; Han SH; Ryu HG; Park SJ; Kim KT; Choi KY
    Mol Cells; 2017 Sep; 40(9):621-631. PubMed ID: 28927264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.
    Dreas A; Mikulski M; Milik M; Fabritius CH; Brzózka K; Rzymski T
    Curr Med Chem; 2017; 24(28):3025-3053. PubMed ID: 28164761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus.
    Nichols RJ; Wiebe MS; Traktman P
    Mol Biol Cell; 2006 May; 17(5):2451-64. PubMed ID: 16495336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.
    Patel O; Dai W; Mentzel M; Griffin MD; Serindoux J; Gay Y; Fischer S; Sterle S; Kropp A; Burns CJ; Ernst M; Buchert M; Lucet IS
    Structure; 2016 Sep; 24(9):1550-61. PubMed ID: 27545623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure, Roles and Inhibitors of a Mitotic Protein Kinase Haspin.
    Kestav K; Uri A; Lavogina D
    Curr Med Chem; 2017; 24(21):2276-2293. PubMed ID: 28413956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the putative binding conformation of a pyrazolopyridine class of inhibitors of MAPKAPK2 using computational studies.
    Miglani R; Cliffe IA; Voleti SR
    Eur J Med Chem; 2010 Jan; 45(1):98-105. PubMed ID: 19850376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the role of active site Mn
    Wang L; Yan F
    Biochem Biophys Res Commun; 2019 Apr; 511(3):612-618. PubMed ID: 30826056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting oncogenic Raf protein-serine/threonine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2018 Sep; 135():239-258. PubMed ID: 30118796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the VRK (vaccinia-related kinase) gene family of p53 regulators in murine hematopoietic development.
    Vega FM; Gonzalo P; Gaspar ML; Lazo PA
    FEBS Lett; 2003 Jun; 544(1-3):176-80. PubMed ID: 12782311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.
    Reich SH; Sprengeler PA; Chiang GG; Appleman JR; Chen J; Clarine J; Eam B; Ernst JT; Han Q; Goel VK; Han EZR; Huang V; Hung INJ; Jemison A; Jessen KA; Molter J; Murphy D; Neal M; Parker GS; Shaghafi M; Sperry S; Staunton J; Stumpf CR; Thompson PA; Tran C; Webber SE; Wegerski CJ; Zheng H; Webster KR
    J Med Chem; 2018 Apr; 61(8):3516-3540. PubMed ID: 29526098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anchor-based classification and type-C inhibitors for tyrosine kinases.
    Hsu KC; Sung TY; Lin CT; Chiu YY; Hsu JT; Hung HC; Sun CM; Barve I; Chen WL; Huang WC; Huang CT; Chen CH; Yang JM
    Sci Rep; 2015 Jun; 5():10938. PubMed ID: 26077136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
    Lopez-Borges S; Lazo PA
    Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MAP kinase-interacting kinases--emerging targets against cancer.
    Diab S; Kumarasiri M; Yu M; Teo T; Proud C; Milne R; Wang S
    Chem Biol; 2014 Apr; 21(4):441-452. PubMed ID: 24613018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting cancer with small molecule kinase inhibitors.
    Zhang J; Yang PL; Gray NS
    Nat Rev Cancer; 2009 Jan; 9(1):28-39. PubMed ID: 19104514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.